Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
29.99
-1.41 (-4.49%)
At close: Feb 11, 2026, 4:00 PM EST
31.16
+1.16 (3.87%)
Pre-market: Feb 12, 2026, 7:46 AM EST

Tyra Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
1,601731596318572-
Market Cap Growth
97.78%22.61%87.61%-44.42%--
Enterprise Value
1,33237738757260-
Last Close Price
30.0013.9013.857.6014.07-
PB Ratio
5.702.132.921.231.90-
P/TBV Ratio
5.712.132.921.231.90-
Debt / Equity Ratio
0.020.020.030.010.000.01
Quick Ratio
17.4523.5313.3244.0783.578.19
Current Ratio
17.7123.8113.8145.1384.098.22
Return on Equity (ROE)
-34.75%-31.60%-29.92%-19.77%-16.66%-201.38%
Return on Assets (ROA)
-23.08%-22.09%-20.31%-12.86%-10.18%-70.27%
Return on Capital Employed (ROCE)
-44.10%-29.90%-38.00%-22.60%-8.70%-65.70%
Earnings Yield
-6.98%-11.83%-11.59%-17.41%-4.60%-
FCF Yield
-5.70%-9.63%-8.54%-16.00%-4.27%-
Buyback Yield / Dilution
-11.70%-33.98%-1.96%-203.94%-793.58%41.81%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q